PRTN3 and rheumatoid arthritis: IgG anti-citrullinated protein antibody (ACPA) and IgM rheumatoid factor (RF) positivity are used in current RA guidelines as poor prognostic factors for second-line treatment decisions and thus stratify patients into autoantibody positive and negative RA [1].